Neurostimulation Devices Market Growth Analysis with Forecast to 2026

Neurostimulation devices market has witnessed commendable proceeds over the years due to a large number of people affected with severe neurologic and psychiatric diseases. These include Alzheimer’s disease, lower back pain, Parkinson’s disease as well as dementia. In a rapidly evolving industry, medical professionals are aiming at developing new treatments for chronic conditions by integrating effectively AI capabilities that may facilitate developments of invasive as well as non-invasive brain-computer interfaces. Emerging technologies in this field carry the potential to restore vision and the movement after paralysis and traumatic injury which holds a wide potential for the product in the coming times.

Get sample copy of this research report @ https://www.decresearch.com/request-sample/detail/436

With an upsurge in spinal cord injuries, traction for spinal cord stimulator will potentially witness an upswing across the globe. According to The National Spinal Cord Injury Database, there are around 54 cases per one million people in the U.S., which translates into 17,810 new spinal cord injuries cases each year.

Spinal cord stimulators are gaining traction in light of surge in the number of minimally invasive procedures. A notable spike in the number of individuals suffering from chronic back pain has further triggered the growth of spinal cord stimulators. Spinal cord stimulators segment is poised to expand at a CAGR of around 12% through 2026.

There has also been an upsurge in Parkinson’s disease that has furthered the use of neurostimulation devices. The Parkinson’s disease portfolio accounted for approximately 7% market share in 2019, an upsurge is projected in the next five years. According to the Parkinson’s Foundation, around 60,000 Americans are diagnosed with Parkinson’s disease every year. Rampant Parkinson’s disease is likely to augur well for the stakeholders eyeing to expand their penetration in the untapped areas.

The U.K. neurostimulation devices market has registered notable gains in the past few decades. In the year 2019, it had reached USD 400 million in total annual remunerations. Surging use of minimally invasive techniques as compared to the conventional surgical methods has amplified the demand for neurostimulation devices.

Neurostimulation device companies are constantly working to enhance their offerings to increase their geographical reach as well as achieve a competitive edge. In October 2019, American technology co. Neuronetics announced its alliance with Success TMS towards the treatment of major depressive disorders in adult patients. Under this three-year agreement, Success TMS will provide Neuronetics’s novel NeuroStar Advanced Therapy system across the U.S.  

Forward-looking companies are likely to focus on the product roll outs, mergers & acquisitions and partnerships. For instance, Medtronic received green signal from FDA for the use of Percept PC deep brain stimulation system (DBS) in June 2020. Some of the leading companies profiled in the neurostimulation devices market are IntraPace, Medtronic, Abbott, Boston Scientific, Bayer AG, LivaNova, Laborie and IntraPace, among others.  

Request for a Customization of this research report @ https://www.decresearch.com/roc/436

Partial Chapter of the Table of Content

Chapter 4. Neurostimulation Devices Market, By Product

4.1. Key segment trends

4.2. Deep brain stimulators

4.2.1.    Market size, by region, 2015-2026 (USD Million)

4.3. Gastric electric stimulators

4.3.1.    Neurostimulation Devices Market size, by region, 2015-2026 (USD Million)

4.4. Spinal cord stimulators

4.4.1.    Market size, by region, 2015-2026 (USD Million)

4.5. Sacral nerve stimulators

4.5.1.    Neurostimulation Devices Market size, by region, 2015-2026 (USD Million)

4.6. Vagus nerve stimulators

4.6.1.    Market size, by region, 2015-2026 (USD Million)

4.6.2.    Invasive

4.6.2.1.    Market size, by region, 2015-2026 (USD Million)

4.6.3.    Non-invasive

4.6.3.1.    Market size, by region, 2015-2026 (USD Million)

Chapter 5. Neurostimulation Devices Market, By Application

5.1. Key segment trends

5.2. Pain management

5.2.1.    Market size, by region, 2015-2026 (USD Million)

5.3. Epilepsy

5.3.1.    Market size, by region, 2015-2026 (USD Million)

5.4. Essential tremor

5.4.1.    Market size, by region, 2015-2026 (USD Million)

5.5. Urinary and fecal incontinence

5.5.1.    Market size, by region, 2015-2026 (USD Million)

5.6. Depression

5.6.1.    Neurostimulation Devices Market size, by region, 2015-2026 (USD Million)

5.7. Dystonia

5.7.1.    Market size, by region, 2015-2026 (USD Million)

5.8. Gastroparesis

5.8.1.    Market size, by region, 2015-2026 (USD Million)

5.9. Parkinson’s disease

Browse complete Table of Contents (ToC) of this research report @ https://www.decresearch.com/toc/detail/neurostimulation-devices-market-report